Literature DB >> 29391719

Clear-cell variant of squamous cell carcinoma in maxilla as primary lesion: A rare case.

Anju Devi1, Mala Kamboj1, Virender Singh2, Sunita Singh3.   

Abstract

Oral squamous cell carcinoma with prominent clear-cell differentiation is a rare occurrence with incompletely understood etiology. We report a case of a 55-year-old male working in a steel factory presented with an ulcerated swelling on maxillary alveolar ridge, a rare site. Histopathology showed sheets of squamous cells with clear cell differentiation and features of malignancy. Periodic acid-Schiff and mucicarmine stains showed negative reaction. Immunohistochemical study using antibody for cytokeratin and epithelial membrane antigen revealed diffuse and intense positivity. The neoplastic cells showed complete negative reaction with antibodies for S-100 and vimentin.

Entities:  

Keywords:  Clear cell; maxillary alveolus; oral squamous cell carcinoma; ulcerated swelling

Year:  2017        PMID: 29391719      PMCID: PMC5763867          DOI: 10.4103/jomfp.JOMFP_180_16

Source DB:  PubMed          Journal:  J Oral Maxillofac Pathol        ISSN: 0973-029X


INTRODUCTION

Head and neck cancers represent approximately 3% of all malignancies. In the oral cavity, more than 90% of primary malignancies are squamous cell carcinomas (SCCs).[1] Histopathologically, it is graded into well, moderate and poorly differentiated lesion, based on the keratinization and degree of anaplasia. Other histologically recognized variants of oral SCC include verrucous, spindle, adenosquamous and basaloid.[2] Neoplasms with prominent clear-cell component in oral cavity are very rare and usually represent as a variant of salivary gland tumors or the result of renal metastasis.[1] Clear-cell SCC (CCSCC) is a rare entity, and a total of seven cases are reported in skin.[3] An exhaustive search on Google Scholar produced only four cases in the oral cavity till date, of which two are glycogen free, like ours indicating the rarity of this oral variant[1245] [Table 1]. Thus, the reported case is the third well-documented case of glycogen-free clear-cell variant of oral SCC in English literature and the first case in maxilla, and thereby being a rare entity, it is making an important contribution to the knowledge regarding this uncommon lesion in oral cavity.
Table 1

Five reported cases of clear-cell variant of squamous cell carcinoma (2012-2016)

Five reported cases of clear-cell variant of squamous cell carcinoma (2012-2016)

CASE REPORT

A 55-year-old male presented with 6 months history of pain and swelling secondary to extraction of teeth in the left posterior region of maxilla. On examination, an ulcerated swelling extending from 23 to 28 was observed with buccal cortical plate expansion in relation to 23–25. In the posterior part of the swelling, an ulcer measuring 3–5 cm with raw floor and everted margins was present [Figure 1]. On palpation, the swelling was tender, fluctuant and compressible. Left cervical lymph nodes were palpable and fixed. Extraorally, the swelling in the left maxillary region caused obvious facial asymmetry.
Figure 1

Intraoral picture showing ulcerated swelling on left side of maxillary ridge

Intraoral picture showing ulcerated swelling on left side of maxillary ridge Ultrasonography revealed hypoechoic lymph node measuring 3.6 cm × 1.7 cm in the left cervical region. Bilateral lobes of isthmus of thyroid, liver, cardiovascular system, pancreas and both kidneys were normal. Cone-beam computed tomography exhibited superficial erosion with respect to the left-side roof of maxillary sinus, zygomatic buttress and infraorbital region. Furthermore, there was complete obliteration of left maxillary sinus and nasal cavity [Figure 2].
Figure 2

Cone-beam computed tomography showing superficial erosion with respect to left side roof of maxillary sinus, zygomatic buttress and infraorbital region. It also shows complete obliteration of left maxillary sinus and nasal cavity

Cone-beam computed tomography showing superficial erosion with respect to left side roof of maxillary sinus, zygomatic buttress and infraorbital region. It also shows complete obliteration of left maxillary sinus and nasal cavity Fine-needle aspiration cytology from the left cervical lymph node revealed atypical cells showing pleomorphism and nuclear hyperchromasia. Based on clinical, aspiration cytology and radiographic findings, a provisional diagnosis of SCC was made and incisional biopsy was performed under local anesthesia. Microscopically, sections stained with hematoxylin and eosin indicated dysplastic stratified squamous epithelium exhibiting transition to an infiltrating tumor composed of lobules of malignant squamous cells separated by delicate fibrous connective tissue stroma. Sheets of clear cells were interspersed among the lobules of dysplastic epithelial cells indicating clear cell changes. The clear cells were round to polygonal having clear cytoplasm with dysplastic features such as nuclear and cellular pleomorphism, hyperchromatic nuclei and abnormal mitosis suggesting malignancy [Figure 3a–d]. Tissue sections were subjected to histochemical and immunohistochemical (IHC) analysis to know the origin of tumor cells.
Figure 3

(a) Histopathologic picture showing dysplastic surface epithelium containing cells with large, pleomorphic and hyperchromatic nuclei, infilterating the connective tissue stroma (H&E, ×4). (b) Sheets of clear cells with features of dysplasia (H&E, ×10). (c) Tumor cells with clear cytoplasm and centrally placed nuclei (H&E, ×20) and (d) (H&E, ×40)

(a) Histopathologic picture showing dysplastic surface epithelium containing cells with large, pleomorphic and hyperchromatic nuclei, infilterating the connective tissue stroma (H&E, ×4). (b) Sheets of clear cells with features of dysplasia (H&E, ×10). (c) Tumor cells with clear cytoplasm and centrally placed nuclei (H&E, ×20) and (d) (H&E, ×40) Microscopic sections stained with periodic acidSchiff (PAS) and mucicarmine showed negative reaction. Neoplastic cells were immunoreactive for cytokeratin (CK) and epithelial membrane antigen (EMA) [Figure 4a and b]. However, no staining occurred with S-100 and vimentin [Figure 4c and d].
Figure 4

(a and b) Immunohistochemical picture showing clear cells with strong immunoreactivity for cytokeratin and epithelial membrane antigen. (c and d) Clear cells with negative results for S100 and Vimentin

(a and b) Immunohistochemical picture showing clear cells with strong immunoreactivity for cytokeratin and epithelial membrane antigen. (c and d) Clear cells with negative results for S100 and Vimentin Considering histopathological, histochemical and IHC examination, a final diagnosis of clear-cell variant of SCC was established. The patient subsequently underwent hemimaxillectomy with radical neck dissection of left side. The excised biopsy submitted to histopathological examination showed that the margins of excised tissue were free of tumor cells, but the cervical lymph node revealed sheets of dysplastic clear cells, obliterating its normal architecture, hence proving metastasis. During follow-up over 5 months, the patient is taking radiation therapy.

DISCUSSION

CCSCC is an extremely rare variant of SCC and was first described by Kuo in 1980. It is also referred to as hydropic SCC. The clear-cell appearance is attributable to hydropic degeneration of neoplastic cells and the accumulation of intracellular fluid, not the accumulation of glycogen, lipid or mucin. All cases of CCSCC have been found in head and neck region, with mandible being the most common site whereas ours is the only case which is present in maxilla. It commonly appears as a nodule or mass that may occasionally be ulcerated.[67] The possible etiological factors include immune suppression, arsenic exposure, radiation and chronic ulceration.[6] As the present case occurred in a patient working in steel factory, radiation can be the cause, but more number of cases should be published to support this assumption. Clear-cell tumors constitute a heterogeneous group of lesions and can be broadly classified into three main categories (odontogenic, salivary glands and metastatic), according to their presumed origin which were considered as differentials for the present case [Table 2].[4]
Table 2

Differential diagnosis of clear cell squamous cell carcinoma

Differential diagnosis of clear cell squamous cell carcinoma Clear-cell odontogenic tumors are clear-cell variant of calcifying epithelial odontogenic tumor (CCCEOT), clear-cell odontogenic carcinoma (CCOC) and clear-cell odontogenic ghost cell tumor (CCGCOT).[8] CCCEOT lacks the characteristic calcifications and amyloid deposition.[9] CCGCOT can be ruled out on acount of presence of ghost cells. PAS-positive, diastase sensitive cytoplasmic granules and CKs 13,18 and 19 positive clear cells must be present to rule out Clear cell odontogenic carcinoma.[10] Salivary gland tumors including epithelial myoepithelial carcinoma, hyalinizing clear-cell carcinoma, clear-cell acinic cell carcinomas and clear-cell mucoepidermoid carcinoma can be considered in differential diagnosis of clear cell tumors. Lack of presence of glycogen, mucin and negative staining for S-100 ruled out epithelial myoepithelial carcinoma, mucoepidermoid carcinoma and clear-cell acinic cell carcinomas. Furthermore, epithelial-myoepithelial carcinoma reveals duct-like structures composed of an inner cuboidal cell layer and outer clear myoepithelial cell layer. These bilayered ductal structures were not seen in our case. Clear-cell variant of acinic-cell carcinoma presents neoplastic cells with serous acinar differentiation which was also not seen in present case. Hyalinizing clear-cell carcinoma was ruled out on account of the lack of dense fibrous stroma.[14] The metastatic deposits containing clear cells may morphologically mimic salivary gland tumors as well as odontogenic tumors, but renal-cell carcinoma is characterized by a prominent sinusoidal vascular component with hemorrhagic foci.[9] General physical examination, chest X-ray and ultrasonography ruled out distance metastasis. Melanocytic tumors stain was positive for S-100. The present case showed negative results for S-100 and vimentin and strong positivity for CK and EMA. Frazier et al.[1] studied numerous case series on SCC, but no cases of CCSCC were identified. Same way, in our institute also, we did not find any case of CCSCC between 2011 and 2016. Although SCC is the most common tumor of oral cavity, its clear-cell variant as primary lesion in oral mucosa is very rare.

CONCLUSION

CCSCC is a rare malignant neoplasm of oral cavity and ours is the only reported case in maxilla. As only few cases in oral cavity have been reported in English literature, more reports on such cases should be documented for better understanding of its etiology, clinical behavior and prognosis.

Declaration of patient consent

The authors certify that they have obtained all appropriate patient consent forms. In the form the patient(s) has/have given his/her/their consent for his/her/their images and other clinical information to be reported in the journal. The patients understand that their names and initials will not be published and due efforts will be made to conceal their identity, but anonymity cannot be guaranteed.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.
  8 in total

Review 1.  Histologic variants of squamous cell carcinoma of the skin.

Authors:  M H Rinker; N A Fenske; L A Scalf; L F Glass
Journal:  Cancer Control       Date:  2001 Jul-Aug       Impact factor: 3.302

2.  Clear cell odontogenic carcinoma: a clinicopathologic and immunocytochemical study of 5 cases.

Authors:  T J Li; S F Yu; Y Gao; E B Wang
Journal:  Arch Pathol Lab Med       Date:  2001-12       Impact factor: 5.534

3.  Clear cell variant of squamous cell carcinoma of skin: A report of a case.

Authors:  Ahmed Oluwatoyin Lawal; Akinyele Olumuyiwa Adisa; Mofoluwaso A Olajide; Adeola Adenike Olusanya
Journal:  J Oral Maxillofac Pathol       Date:  2013-01

4.  A rare case report of clear cell variant of oral squamous cell carcinoma.

Authors:  Purshotam Nainani; Harkanwal Preet Singh; Aparna Paliwal; Neelu Nagpal
Journal:  J Clin Diagn Res       Date:  2014-12-05

5.  Primary glycogen-rich clear cell squamous cell carcinoma of the mandibular gingiva.

Authors:  John J Frazier; Harry Sacks; Paul D Freedman
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol       Date:  2012-05-22

6.  Clear cell odontogenic carcinoma of maxilla: A case report and mini review.

Authors:  Niharika Swain; Richa Dhariwal; Jay Gopal Ray
Journal:  J Oral Maxillofac Pathol       Date:  2013-01

7.  Histopathological variants of cutaneous squamous cell carcinoma: a review.

Authors:  Valerie R Yanofsky; Stephen E Mercer; Robert G Phelps
Journal:  J Skin Cancer       Date:  2010-12-29

8.  A rare case of clear cell variant of oral squamous cell carcinoma.

Authors:  Sriram Kaliamoorthy; Vijayparthiban Sethuraman; Sathish Muthukumar Ramalingam; Sandhya Arunkumar
Journal:  J Nat Sci Biol Med       Date:  2015 Jan-Jun
  8 in total
  5 in total

1.  Do Clear Cell Changes in Oral Squamous Cell Carcinoma Warrant It Being Recognised as a Variant?

Authors:  Nurul Inaas Mahamad Apandi; Anand Ramanathan; Siti Mazlipah Ismail; Kannan Ranganathan
Journal:  Cureus       Date:  2022-05-16

2.  Clear-cell variant of oral squamous cell carcinoma: A rare entity.

Authors:  Pratibha Ramani; S Gheena; Monika Karunagaran; R Hannah
Journal:  J Oral Maxillofac Pathol       Date:  2021-03-19

3.  Clear cell variant squamous cell carcinoma of temporal bone: Case report and literature review.

Authors:  Abdulaziz S AlEnazi; Fahad A Alwadi; Yazeed A AlOqaili
Journal:  Int J Surg Case Rep       Date:  2018-09-01

4.  Clear cell variant of oral squamous cell carcinoma: case report and review.

Authors:  Rutuja Narsing Mukkanwar; Sangeeta Palaskar; Rasika Pawar; Darshana Rajesh Shah
Journal:  Autops Case Rep       Date:  2022-07-18

5.  Oral metastatic clear-cell tumours: To and fro: Unusual case reports.

Authors:  Preeti Sharma; Vijay Wadhwan; Roli Singh
Journal:  J Oral Maxillofac Pathol       Date:  2022-06-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.